Focus on acute leukemias

被引：137

作者：

Gilliland, DG

Tallman, MS

机构：

[1] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Harvard Inst Med, Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA

来源：

CANCER CELL | 2002年 / 1卷 / 05期

关键词：

D O I：

10.1016/S1535-6108(02)00081-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：417 / 420

页数：4

共 33 条

[1] MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia [J].

Armstrong, SA ;

Staunton, JE ;

Silverman, LB ;

Pieters, R ;

de Boer, ML ;

Minden, MD ;

Sallan, SE ;

Lander, ES ;

Golub, TR ;

Korsmeyer, SJ .

NATURE GENETICS, 2002, 30 (01) :41-47

[2] Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype [J].

Aversa, F ;

Tabilio, A ;

Velardi, A ;

Cunningham, I ;

Terenzi, A ;

Falzetti, F ;

Ruggeri, L ;

Barbabietola, G ;

Aristei, C ;

Latini, P ;

Reisner, Y ;

Martelli, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17) :1186-1193

[3]

Bloomfield CD, 1998, CANCER RES, V58, P4173

[4]

Büchner T, 1999, BLOOD, V93, P4116

[5] Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial [J].

Burnett, AK ;

Goldstone, AH ;

Stevens, RMF ;

Hann, IM ;

Rees, JKH ;

Gray, RG ;

Wheatley, K .

LANCET, 1998, 351 (9104) :700-708

[6] Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission [J].

Cassileth, PA ;

Harrington, DP ;

Appelbaum, FR ;

Lazarus, HM ;

Rowe, JM ;

Paietta, E ;

Willman, C ;

Hurd, DD ;

Bennett, JM ;

Blume, KG ;

Head, DR ;

Wiernik, PH .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23) :1649-1656

[7] The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia [J].

Castilla, LH ;

Garrett, L ;

Adya, N ;

Orlic, D ;

Dutra, A ;

Anderson, S ;

Owens, J ;

Eckhaus, M ;

Bodine, D ;

Liu, PP .

NATURE GENETICS, 1999, 23 (02) :144-146

[8] Molecular genetics of acute myeloid leukaemia [J].

Dash, A ;

Gilliland, DG .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (01) :49-64

[9] A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia [J].

Fenaux, P ;

Chastang, C ;

Chevret, S ;

Sanz, M ;

Dombret, H ;

Archimbaud, E ;

Fey, M ;

Rayon, C ;

Huguet, F ;

Sotto, JJ ;

Gardin, C ;

Makhoul, PC ;

Travade, P ;

Solary, E ;

Fegueux, N ;

Bordessoule, D ;

San Miguel, J ;

Link, H ;

Desablens, B ;

Stamatoullas, A ;

Deconinck, E ;

Maloisel, F ;

Castaigne, S ;

Preudhomme, C ;

Degos, L .

BLOOD, 1999, 94 (04) :1192-1200

[10] Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia [J].

Ferrando, AA ;

Neuberg, DS ;

Staunton, J ;

Loh, ML ;

Huard, C ;

Raimondi, SC ;

Behm, FG ;

Pui, CH ;

Downing, JR ;

Gilliland, DG ;

Lander, ES ;

Golub, TR ;

Look, AT .

CANCER CELL, 2002, 1 (01) :75-87

← 1 2 3 4 →